Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 and its vaccines can cause hair loss, which is not serious and can improve with psychological support.

COVID-19 can cause hair loss and nail changes in some patients.

Anagen effluvium is a reversible condition causing sudden hair loss, often due to chemotherapy or head radiation.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

Children with different rheumatologic diseases have specific skin symptoms that can help with diagnosis.

About 22% of cancer patients had skin-related side effects from chemotherapy, but these were usually not severe enough to halt treatment.

The paper concludes that detailed patient history, skin exams, and lab tests are crucial for diagnosing and treating hair loss from diffuse alopecia.

A critically ill boy experienced hair loss likely due to the stress of his medical treatments, but his hair regrew completely in 1.5 months.

A man got six skin cancers within a year after a cell transplant for leukemia but was cancer-free 32 months later; skin checks are important post-transplant.

Common types of non-scarring hair loss have various causes and treatments, but more effective solutions are needed.

Up to 50% of women may experience significant hair loss by age 50, with various causes and treatments available.

The document concludes that accurate diagnosis and appropriate management are crucial for treating various hair disorders, which have significant psychological impacts.

The drug Albendazole, used for treating parasites, can cause sudden hair loss.

A woman's hair turned white after taking a cancer drug called dasatinib.

The study concluded that hair loss treatments should be tailored to the specific type of alopecia and individual patient needs.

A woman experienced hair loss after taking strontium ranelate for osteoporosis.

The document concludes that most patients with endocrine disorders experience diffuse, non-scarring hair loss, with scarring hair loss being rare.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

Some medications can cause hair loss, but stopping the drug usually leads to recovery within 3 months.

Etretinate treatment changed hair growth patterns in many patients.

Lichen sclerosus et atrophicus is generally not considered precancerous, but there are exceptions.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

Teloptosis is a key point in hair loss that could help in creating prevention-focused hair care strategies.

Telogen Effluvium is a condition causing excessive hair loss due to stress, illness, drugs, or hormonal changes, and can be treated with specific products or naturally resolves after 3-4 years.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

Most hair loss in children is caused by a few common conditions, and it's important to diagnose these properly and support the child's mental health.

Up to 50% of scalp hair can be lost before it appears thin, and treatment is only needed for hair loss caused by diseases or deficiencies.

The document concludes that using specific tools and tests is essential for identifying the cause of hair loss and deciding on the right treatment.

Obese mice with a leptin gene mutation have a longer resting phase in their hair cycle, which may help understand certain hair loss conditions.